相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。International Classification of Retinopathy of Prematurity, Third Edition
Michael F. Chiang et al.
OPHTHALMOLOGY (2021)
Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity
David K. Wallace et al.
JAMA OPHTHALMOLOGY (2020)
VEGF in Signaling and Disease: Beyond Discovery and Development
Rajendra S. Apte et al.
CELL (2019)
Retinopathy of prematurity - A world update
Brian A. Darlow et al.
SEMINARS IN PERINATOLOGY (2019)
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial
Andreas Stahl et al.
LANCET (2019)
Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
Aaron B. Simmons et al.
ANGIOGENESIS (2018)
A Dosing Study of Bevacizumab for Retinopathy of Prematurity Late Recurrences and Additional Treatments
David K. Wallace et al.
OPHTHALMOLOGY (2018)
Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Muller cells maintains retinal function by triggering different signaling mechanisms
Silke Becker et al.
SCIENTIFIC REPORTS (2018)
Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
Mari Jeeva Sankar et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity A Phase 1 Dosing Study
David K. Wallace et al.
JAMA OPHTHALMOLOGY (2017)
Mechanisms and regulation of endothelial VEGF receptor signalling
Michael Simons et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
NRP1 function and targeting in neurovascular development and eye disease
Claudio Raimondi et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2016)
Targeting VEGF in canine oxygen-induced retinopathy - a model for human retinopathy of prematurity
D. Scott McLeod et al.
EYE AND BRAIN (2016)
Neuropilin-1-Expressing Microglia Are Associated With Nascent Retinal Vasculature Yet Dispensable for Developmental Angiogenesis
Agnieszka Dejda et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis
Wan-Jen Yang et al.
EMBO MOLECULAR MEDICINE (2015)
Pathophysiology and Mechanisms of Severe Retinopathy of Prematurity
M. Elizabeth Hartnett
OPHTHALMOLOGY (2015)
Neuropilin regulation of angiogenesis
Anastasia Lampropoulou et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Vascular Endothelial Growth Factor Antagonist Therapy for Retinopathy of Prematurity
M. Elizabeth Hartnett
CLINICS IN PERINATOLOGY (2014)
Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis
Alessandro Fantin et al.
DEVELOPMENT (2014)
Targeting Muller Cell-Derived VEGF164 to Reduce Intravitreal Neovascularization in the Rat Model of Retinopathy of Prematurity
Yanchao Jiang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Short Hairpin RNA-Mediated Knockdown of VEGFA in Muller Cells Reduces Intravitreal Neovascularization in a Rat Model of Retinopathy of Prematurity
Haibo Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Effects of oxygen on the development and severity of retinopathy of prematurity
M. Elizabeth Hartnett et al.
JOURNAL OF AAPOS (2013)
Prolyl Hydroxylase Inhibition During Hyperoxia Prevents Oxygen-Induced Retinopathy in the Rat 50/10 Model
George Trichonas et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Anti-VEGF Antibody Leads to Later Atypical Intravitreous Neovascularization and Activation of Angiogenic Pathways in a Rat Model of Retinopathy of Prematurity
Manabu McCloskey et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Reduction of Retinopathy of Prematurity in Extremely Low Gestational Age Newborns Treated with Recombinant Human Cu/Zn Superoxide Dismutase
Richard B. Parad et al.
NEONATOLOGY (2012)
Mechanisms and Management of Retinopathy of Prematurity
M. Elizabeth Hartnett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The cytoplasmic domain of neuropilin 1 is dispensable for angiogenesis, but promotes the spatial separation of retinal arteries and veins
Alessandro Fantin et al.
DEVELOPMENT (2011)
Understanding Retinopathy of Prematurity: Update on Pathogenesis
Jose Carlos Rivera et al.
NEONATOLOGY (2011)
Efficacy of Intravitreal Bevacizumab for Stage 3+Retinopathy of Prematurity.
Helen A. Mintz-Hittner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the Eye
Hu Huang et al.
PLOS ONE (2011)
Effect of VEGF Trap on Normal Retinal Vascular Development and Oxygen-Induced Retinopathy in the Dog
Gerard A. Lutty et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Association of Retinal Vascular Endothelial Growth Factor With Avascular Retina in a Rat Model of Retinopathy of Prematurity
Steven J. Budd et al.
ARCHIVES OF OPHTHALMOLOGY (2010)
Increased Angiogenic Factors Associated With Peripheral Avascular Retina and Intravitreous Neovascularization A Model of Retinopathy of Prematurity
Steven J. Budd et al.
ARCHIVES OF OPHTHALMOLOGY (2010)
Astrocyte Hypoxic Response Is Essential for Pathological But Not Developmental Angiogenesis of the Retina
Alexander Weidemann et al.
GLIA (2010)
Muller cell-derived VEGF is a significant contributor to retinal neovascularization
Yanyan Bai et al.
JOURNAL OF PATHOLOGY (2009)
Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1
Claudia Prahst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy
Jonathan E. Sears et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: Relevance to plus disease
M. Elizabeth Hartnett et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
The semaphorins: versatile regulators of tumour progression and tumour angiogenesis
Gera Neufeld et al.
NATURE REVIEWS CANCER (2008)
Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation
Gefei Zeng et al.
BLOOD (2007)
VEGF receptor signalling - in control of vascular function
AK Olsson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy
M Al-Shabrawey et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Vascular endothelial growth factor-B and retinal vascular development in the mouse
M Reichelt et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2003)
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1
A Luttun et al.
NATURE MEDICINE (2002)
Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division
JB Kearney et al.
BLOOD (2002)
Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): A mechanism contributing to VEGF-induced angiogenesis
H Oh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
VEGF(165) mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF(165)-receptor binding
S Soker et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF165 and VEGF121
GB Whitaker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development
GS Robinson et al.
FASEB JOURNAL (2001)
Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization
H Ozaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
